- Capital Cube•2 months ago
Aoxing Pharmaceutical Co., Inc. relative valuation is UNDERVALUED and it has a fundamental analysis score of 69.Our analysis is based on comparing Aoxing Pharmaceutical Co., Inc. with the following peers – Pfizer Inc., Catalyst Pharmaceuticals, Inc., BioDelivery Sciences International, Inc., Impax Laboratories, Inc., Johnson & Johnson, Mylan N.V., Omeros Corporation, Amicus Therapeutics, Inc., Onconova Therapeutics […] (Read more...) The post Aoxing Pharmaceutical Co., Inc.: Price momentum supported by strong fundamentals appeared first on CapitalCube.
- Benzinga•2 months ago
Aoxing Pharmaceutical Company, Inc. (NYSE MKT: AXN ) disclosed that it commenced commercial production of Tilidine Hydrochloride tablets, which is a narcotic drug product. According to the company, this ...
- Accesswire•2 months ago
FOSTER CITY, CA / ACCESSWIRE / June 30, 2016 / Aoxing Pharmaceutical Company, Inc. (NYSE MKT: AXN) ("Aoxing Pharma"), a specialty pharmaceutical company focusing on research, development, manufacturing, ...
Aoxing Pharmaceutical Company, Inc. (AXN)
NYSE MKT - NYSE MKT Real Time Price. Currency in USD
|Bid||0.62 x 1600|
|Ask||0.74 x 200|
|Day's Range||0.64 - 0.65|
|52wk Range||0.58 - 1.86|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||5.77|
|Avg Vol (3m)||99,901|
|Dividend & Yield||N/A (N/A)|